As of 2025-03-17, the Relative Valuation of Albireo Pharma Inc (ALBO) is (65.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -248.9%.
The range of the Relative Valuation is (32.24) - (97.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.6x - 16.5x | 10.6x |
| Forward P/E multiples | 5.1x - 15.4x | 10.2x |
| Fair Price | (32.24) - (97.36) | (65.75) |
| Upside | -173.0% - -320.5% | -248.9% |
| Date | P/E |